US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects ...

The approval comes less than a year Bristol Myers Squibb paid $14 billion to acquire the developer of the drug, Karuna ...

Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...

A contract for the running of a youth alcohol and other drug rehabilitation centre has been awarded to a Far North ...

The facility will offer inpatient and outpatient services, including long-term stays, detox, individual and group therapy.

Giving women at risk of premature birth a simple magnesium sulfate infusion (or ‘drip’) can prevent their babies from ...

In the world of biotechnology, few stories resonate as strongly as that of Pasithea Therapeutics Corp. (NASDAQ: KTTA). On Thursday, the stock saw an impressive surge of +80.31%, reaching $6.90 during ...

A new dose-finding study supported the potential of the carbonic anhydrase inhibitor as an alternative to CPAP machines.

Capricor announced it intends to file a BLA for deramiocel for treatment of patients with DMD cardiomyopathy. Click here to ...

September is National Recovery Month. It's dedicated to promoting treatment and recovery from alcohol and drug addiction.

In newly released data, lenacapavir, given via a twice-yearly injection, has shown remarkable effectiveness at eliminating ...